Deep Dive: Oncology 2021This has probably been the toughest year for oncology researchers in memory. As this issue’s contributors discuss, funding Share XDeep Dive: Oncology 2021https://pharmaphorum.com/views-analysis-oncology/deep-dive-oncology-2021/
Pharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
Climate change: The elephant in the waiting room of healthPharma has both an opportunity and a responsibility to do its part in tackling climate change – and Share XClimate change: The elephant in the waiting room of healthhttps://pharmaphorum.com/views-and-analysis/climate-change-the-elephant-in-the-waiting-room-of-health/
Blockchain: Ready to revolutionise medicinal cannabis research?Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical Share XBlockchain: Ready to revolutionise medicinal cannabis research?https://pharmaphorum.com/views-and-analysis/blockchain-ready-to-revolutionise-medicinal-cannabis-research/
Renal disease: the big pictureRenal diseases represent a formidable challenge on public health systems around the world. They are costly in terms Share XRenal disease: the big picturehttps://pharmaphorum.com/r-d/renal-disease-the-big-picture/
Health Innovators: Fredrik Debong, Hi.HealthIn this episode of our Health Innovators series, Paul Tunnah is joined by tech entrepreneur Fredrik Debong. Fredrik Share XHealth Innovators: Fredrik Debong, Hi.Healthhttps://pharmaphorum.com/video/health-innovators-fredrik-debong-hi-health/
Is cardiovascular disease a ‘pandemic hiding in plain sight’?Amarin’s Craig Granowitz discusses the impact of COVID on cardiovascular disease treatment and explains why there’s still a Share XIs cardiovascular disease a ‘pandemic hiding in plain sight’?https://pharmaphorum.com/views-and-analysis/is-cardiovascular-disease-a-pandemic-hiding-in-plain-sight/
Medication adherence: how to ensure patients are not left behindPoor medication adherence is both a costly issue for pharma manufacturers – with some estimating a loss of Share XMedication adherence: how to ensure patients are not left behindhttps://pharmaphorum.com/views-and-analysis/medication-adherence-how-to-ensure-patients-are-not-left-behind/
Digital strategies for pharma’s physician engagementPharmaceutical sales and marketing operations have been forced to follow a steep learning curve as they adjust to Share XDigital strategies for pharma’s physician engagementhttps://pharmaphorum.com/views-analysis-sales-marketing/digital-strategies-for-pharmas-physician-engagement/
